Ouro Fino Saude Animal Participacoes SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Ouro Fino Saude Animal Participacoes SA with three other
pharmaceutical manufacturers in Latin America:
Laboratorios Richmond SACIF
sales of 3.90 billion Argentinian Pesos [US$53.44 million]
of which 66%
was Private Market),
(2.91 billion Brazilian Reals [US$529.95 million]
of which 84%
was Diagnostic Medicine), and
Instituto Hermes Pardini SA
(1.35 billion Brazilian Reals [US$246.93 million]
of which 100%
was auxiliary diagnostic support services).
During the year ended December of 2019, sales at
Ouro Fino Saude Animal Participacoes SA were 619.59 million Brazilian Reals (US$113.02 million).
increase of 5.2%
versus 2018, when the company's sales were 589.22 million Brazilian Reals.
This was the third consecutive year of growth at Ouro Fino Saude Animal Participacoes SA.
Sales of Internacional Operations saw an increase
that was more than double the company's growth rate: sales were up
16.8% in 2019, from
55.02 million Brazilian Reals to 64.27 million Brazilian Reals.
Ouro Fino Saude Animal Participacoes SA also saw significant increases in sales in
Pets (up 16.7% to 88.23 million Brazilian Reals)